Valeant develops and markets a wide range of OTC products, prescription medicines and medical devices to a number of countries and regions in Asia Pacific, including China, Japan, South Korea, India, Australia, South Africa and Southeast Asia.
In Australia, Valeant has a major presence in the consumer-health market through its acquisitions of well-respected brands in such market segments as dermatology, sun screens, and coughs and colds under the iNova Pharmaceuticals banner.
With the 2013 acquisition of Bausch + Lomb, Valeant’s footprint in Asia more than doubled, as Bausch + Lomb has successfully built an undeniably strong brand in most Asia Pacific markets -- particularly in Greater China, Korea and Japan. Bausch + Lomb was the first company to introduce contact lenses into China, where the company name is used as a synonym for contact lens. Vision care growth in China has been driven by the demand for clear contact lenses, lens care products and cosmetic lenses.
Learn more about iNova Pharmaceuticals at its website.